Human α-defensin 5 suppressed colon cancer growth by targeting PI3K pathway

Qiao Qiao1, Ruixia Bai2, Wanying Song3

  • 1Department of Obstetrics and Gynecology, Affiliated Hospital of Inner Mongolia Medical University, No.1, Tongdao North Street, Huimin District, Hohhot, 010050, PR China.

Experimental Cell Research
|September 6, 2021
PubMed

Insights

Defensin Alpha 5 (DEFA5) acts as a tumor suppressor in colon cancer. Overexpression of DEFA5 inhibits cancer cell proliferation, colony formation, and tumor growth by targeting the PI3K signaling pathway.

Area of Science:

  • * Molecular biology
  • * Oncology
  • * Immunology

Background:

  • * Defensins are conserved antimicrobial peptides with roles in host defense.
  • * Aberrant defensin expression is linked to various cancers, but DEFA5's role in colon cancer is unexplored.
  • * Understanding DEFA5's function is crucial for developing new colon cancer therapies.

Purpose of the Study:

  • * To investigate the expression of Defensin Alpha 5 (DEFA5) in colon cancer.
  • * To elucidate the molecular mechanisms underlying DEFA5's role in colon cancer progression.
  • * To assess the potential of DEFA5 as a therapeutic target for colon cancer.

Main Methods:

  • * Bioinformatic analysis for DEFA5 expression and clinical outcome correlation.
  • * In vitro studies using Western blot, qPCR, and cell culture models.
  • * In vivo xenograft models in nude mice and co-immunoprecipitation assays.

Main Results:

  • * DEFA5 expression was significantly decreased in colon cancer tissues.
  • * Overexpression of DEFA5 suppressed colon cancer cell proliferation and colony formation.
  • * DEFA5 directly binds to PI3K subunits, inhibiting downstream signaling and reducing tumor growth and metastasis in vivo.

Conclusions:

  • * DEFA5 exhibits a tumor suppressor role in colon cancer.
  • * DEFA5 inhibits colon cancer cell growth and metastasis by attenuating PI3K signaling.
  • * DEFA5 represents a potential therapeutic target for colon cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K